CLNN affiliate files Form 144 to sell 477,000 shares

Q: What does CLNN's Form 144 disclose?

It discloses a proposed resale of 477,000 shares of Common Stock under Form 144 procedures. The filing also itemizes multiple open‑market trades by Symbiosis II LLC with dates and gross proceeds from 12/22/2025 to 02/03/2026.

Q: Who is the seller listed in the CLNN filing?

The excerpt lists Symbiosis II LLC as a selling party making open‑market dispositions. The filing shows numerous trades by that entity, each entry including trade date, shares sold, and reported gross proceeds in dollars.

Q: How many shares are shown as proposed for sale in CLNN's Form 144?

The filing shows a proposed sale amount of 477,000 shares of Common Stock. The notice also provides a timeline of executed trades by Symbiosis II LLC with per‑trade share counts and dollar proceeds.

CLNN affiliate submitted a Form 144 notice to sell 477,000 shares of Common Stock.

Accepted by SEC EDGAR 03/24/2026 - 04:36 PM EDT

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

144

Rhea-AI Filing Summary

CLNN affiliate submitted a Form 144 notice to sell 477,000 shares of Common Stock.

The filing lists multiple recent open‑market dispositions by Symbiosis II LLC from 12/22/2025 through 02/03/2026, with per‑trade share counts and gross proceeds reported for each trade.

Insights

Form 144 notice records a proposed affiliate resale and lists recent open‑market trades by a single holder.

The filing shows a proposed sale of 477,000 shares of Common Stock under Form 144 procedures. It lists many executed open‑market transactions by Symbiosis II LLC, each with trade date, share count, and gross proceeds.

Cash‑flow treatment and exact distribution method beyond "open market" are as reported in the excerpt; timing and any conditions tied to the sale are those stated in the filing text.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does CLNN's Form 144 disclose?

It discloses a proposed resale of 477,000 shares of Common Stock under Form 144 procedures. The filing also itemizes multiple open‑market trades by Symbiosis II LLC with dates and gross proceeds from 12/22/2025 to 02/03/2026.

Who is the seller listed in the CLNN filing?

The excerpt lists Symbiosis II LLC as a selling party making open‑market dispositions. The filing shows numerous trades by that entity, each entry including trade date, shares sold, and reported gross proceeds in dollars.

How many shares are shown as proposed for sale in CLNN's Form 144?

The filing shows a proposed sale amount of 477,000 shares of Common Stock. The notice also provides a timeline of executed trades by Symbiosis II LLC with per‑trade share counts and dollar proceeds.

Do the Form 144 entries show recent transactions by the seller?

Yes. The filing lists multiple recent open‑market transactions by Symbiosis II LLC, for example 32,705 shares on 01/12/2026 and 26,105 shares on 01/13/2026, each with gross proceeds reported.

Were the sales executed on an exchange?

The excerpt indicates trades were open‑market transactions and references Nasdaq in the securities header. Individual trade rows list dates, share counts, and dollar proceeds for each open‑market sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

144: Filer Information

Filer CIK

0002006045

Filer CCC

XXXXXXXX

Is this a LIVE or TEST Filing?

LIVE TEST

Submission Contact Information

Name

Phone

E-Mail Address

144: Issuer Information

Name of Issuer

Clene Inc

SEC File Number

001-39834

Address of Issuer

6550 SOUTH MILLROCK DRIVE
SUITE G50
SALT LAKE CITY
UTAH
84121

Phone

8016769695

Name of Person for Whose Account the Securities are To Be Sold

Symbiosis II LLC

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Former Board Member

144: Securities Information

Title of the Class of Securities To Be Sold

Name and Address of the Broker

Number of Shares or Other Units To Be Sold

Aggregate Market Value

Number of Shares or Other Units Outstanding

Approximate Date of Sale

Name the Securities Exchange

Common

Merrill Lynch
555 California St
Ste 1800
San Francisco CA 94104

82212

477000

11778307

03/24/2026

Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class

Date you Acquired

Nature of Acquisition Transaction

Name of Person from Whom Acquired

Is this a Gift?

Date Donor Acquired

Amount of Securities Acquired

Date of Payment

Nature of Payment *

Common

06/20/2023

Open Market Purchase

Issuer

125706

06/20/2023

Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller

Title of Securities Sold

Date of Sale

Amount of Securities Sold

Gross Proceeds